The specialty chemicals Group ALTANA was able to increase sales by 9 percent to €1,070 million in the first half of 2015 (previous year: €985 million).
The specialty chemicals company ALTANA AG has successfully adjusted and extended a syndicated line of credit in the amount of €250 million.
Dr. Matthias L. Wolfgruber (61) is going to retire and will hand over the chairmanship of the Management Board to longtime Management Board member Martin Babilas (43) on January 1, 2016, Stefan Genten (46) will become ALTANA’s new Chief Financial Officer on August 1, 2015
Dr. Stephan Glander (46) has been appointed new Managing Director of BYK-Chemie GmbH, based in Wesel, Germany
Managers and entry-level employees have radically different opinions as to what the most important innovation drivers are. Thirty-four percent of young professionals would like to see more scope for employees.
Prestigious business prize given as part of first annual German Stevie® Awards
One in five industrial corporations holds a stake in a startup, but only one in ten enterprises systematically utilizes external knowledge
Sales rise by 11 percent to around €2 billion, EBITDA reaches €397 million, with a margin of 20.4 percent, Outlook: Further profitable growth in 2015
New development efforts are being focused more closely on customer needs, One in three enterprises will spend more on innovation in 2015, 78 percent of all companies reward good ideas monetarily
ACTEGA acquires two companies in the overprint varnish and printing ink industry in São Paulo state, Takeover of three production facilities and 210 employees, Consolidation of businesses in the new ACTEGA do Brasil
Dr. Christoph Schlünken, President of the BYK Additives & Instruments division, will join ALTANA’s Management Board as of November 1, 2014, Chief Financial Officer Martin Babilas will assume additional responsibilities, Reorganization caters to accelerated growth of the ALTANA Group